AgaMatrix, Inc.

AgaMatrix, Inc. has 1 AI-enabled medical device on the FDA list. The first decision was on November 30, 2016 and the most recent on November 30, 2016 (One Drop Blood Glucose Monitoring System). Its most common review panel is Clinical Chemistry (1 device).